FDA Approved Medical Products for:

Infantile apnea

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Caffeine
Trade Name
(Manufacturer Name)
Cafcit®
(Bedford Laboratories)
Indication
The FDA has approved this product to be used in this manner.
Short term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age.
More Information about this product Drug Information Portal